Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-24 @ 11:15 PM
NCT ID:
NCT03750656
Eligibility Criteria:
Inclusion Criteria:
* Patients must be 18 years of age or older
* Patient must require placement of a ureteral stent(s), per standard of care, following routine urological procedures including, but not limited to, ureteroscopy, stone extraction, or management of upper tract transitional cell carcinoma
* Patient must agree to abstain from other clinical studies during the study period
Exclusion Criteria:
* Patients younger than 18 years of age
* Patients with chronic or pre-existing indwelling stents
* Patients currently receiving anticholinergic or alpha blocker therapy
* Patients with chronic opioid or analgesic usage
* Patients with chronic pain syndrome or symptomatic benign prostatic hyperplasia
* Patients with an active untreated urinary tract infection
* Patients who are currently pregnant or nursing
* Patients with allergies or contraindication to either tamsulosin or hyoscyamine
* Patients on active chemotherapy
* Patients currently receiving other investigational therapy
* Patients who are unable to sign consent/answer questionnaire due to compromised mental capacity or language barrier (the questionnaire is not validated in other languages)
* Patients who have a stent placed emergently for an obstructing stone or septic stone without immediate stone removal,
* Any stents placed that will stay in for longer than 2 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03750656
Study Brief:
Protocol Section:
NCT03750656